SNX10 controls metabolic reprogramming of macrophages in atherosclerosis by enhancing lysosomal biogenesis and lysosomal acid lipase, thus increasing free fatty acids to fuel mitochondrial fatty acid oxidation (57, 58). This evidence concerns the gene LIPA and atherosclerosis.